Posterior urethral complications of the treatment of prostate cancer.

Institute of Urology, London, UK.
BJU International (Impact Factor: 3.05). 02/2012; 110(3):304-25. DOI:10.1111/j.1464-410X.2011.10864.x
Source: PubMed

ABSTRACT • To review the less common and not widely discussed, but much more serious complications of prostate cancer treatment of: urethral stricture, bladder neck contracture and urorectal fistula. • The treatment options for patients with organ-confirmed prostate cancer include: radical prostatectomy (RP), brachytherapy (BT), external beam radiotherapy (EBRT), high-intensity focussed ultrasound (HIFU) and cryotherapy; with each method or combination of methods having associated complications. • Complications resulting from RP are relatively easy to manage, with rapid recovery and return to normal activities, and usually a return to normal bodily functions. • However, after non-surgical treatments, i.e. BT, EBRT, HIFU and cryotherapy, these same problems are more difficult to treat with a much slower return to a much lower level of function. • When counselling patients about the primary treatment of prostate cancer they should be advised that although the same type of complication may occur after surgical or non-surgical treatment, the scope and scale of that complication, the ease with which it is treated and the degree of restoration of normality after treatment, is altogether in favour of surgery in those for whom surgery is appropriate and who are fit for surgery.

0 0
  • [show abstract] [hide abstract]
    ABSTRACT: Bladder neck contracture is a relatively uncommon but well-described complication after the surgical treatment of prostate cancer. Although numerous treatments have been described as an initial management strategy for patients with this condition, the management of refractory cases remains highly variable. This article evaluates various therapeutic maneuvers used for the treatment of refractory bladder neck contracture and further describes the preliminary results of an endoscopic balloon dilation with concomitant deep traunsurethral incision procedure. Short- and long-term management algorithms for patients with recurrent bladder neck contractures are reviewed.
    Urologic Clinics of North America 08/2013; 40(3):371-80. · 1.39 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: To evaluate safety and efficacy of open transperineal reanastomosis (TPRA) for highly recurrent anastomotic strictures (AS) after radical prostatectomy. While the majority of AS can be managed successfully by endoscopic treatment, in highly recurrent AS, open reanastomosis represents a viable therapeutic option. Retrospective analysis by standardized questionnaire, inquiring for recurrence, incontinence, sexual function, satisfaction and changes in quality of life (QoL) in 15 patients undergoing TPRA 08/2007-03/2010. Mean patient age was 65 years (51-75) and mean follow-up 20.5 months (5.8-37.0). Success rate was 93.3 % (14/15). The single recurrence was successfully treated by cold knife incision. Incontinence was found in 93.3 % (14/15) preoperatively and aggravated in 60 % (9/15) after surgery; no de novo incontinence occurred. Implantation of an artificial urinary sphincter (AUS) has been performed successfully in 10 patients, 2 refused implantation and 2 are scheduled for surgery. Erectile dysfunction was present in 86.7 % (13/15); 13.3 % (2/15) reported a severely declined rigidity. Compared to preoperative status, 33.3 % (5/15) complained about impaired erectile function after TPRA. A good or very good subjective overall health status and an improvement in QoL were noted in 86.7 % (13/15). Patient satisfaction with the outcome of TPRA was high or very high in 13; two were undecided. After repeated endoscopic treatment, TPRA is a valuable therapeutic option in selected patients with an overall success rate of 93.3 % (14/15) for anastomotic patency, which can even be raised to 100 % by further transurethral surgery. Incontinence can be easily treated by implantation of an AUS.
    World Journal of Urology 10/2013; · 2.89 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: We recently demonstrated that radiotherapy-induced urethral strictures can be successfully managed with urethroplasty. We increased size and follow-up on our multi-institutional cohort and evaluated excision and primary anastomosis (EPA) as treatment for radiotherapy-induced urethral strictures. A retrospective review of 72 patients treated for radiotherapy-induced bulbomembranous strictures from three academic institutions was performed. Outcome parameters of successful repair included recurrence, incontinence, and erectile dysfunction. Among 72 men treated for radiotherapy-induced strictures, 66 (91.7%) underwent EPA. Mean follow-up was 3.5 years (median 3.1, range 0.8-11.2 years). Prostate cancer was the most common reason for radiotherapy (64/66, 96.9%); external beam radiotherapy and brachytherapy was performed in 28/66 men (42.4%) each, a combination of both in 9 (13.6%). Mean time from radiation to EPA was 6.4 years (range 1-20), mean stricture length 2.3 cm (range 1 to 6). Successful reconstruction was achieved in 46 men (69.7%). Mean time to recurrence was 10.2 months (range 1 to 64), with new onset of incontinence observed in 12 men (18.5%); this was associated with stricture length >2cm (p=0.013) and center of treatment (p<0.001). The rate of erectile dysfunction remained stable (45.6% preoperative, 50.9% postoperative, p=0.71). Type of radiotherapy did not affect stricture length (p=0.41), recurrence risk (p=0.91), post-op incontinence (p=0.88), or erectile dysfunction (p=0.53). Radiotherapy-induced bulbomembranous urethral strictures can be successfully managed with EPA. Substitution urethroplasty with graft or flap is infrequently needed. Patients should be counseled on the potential risks of urinary incontinence and erectile dysfunction.
    The Journal of urology 12/2013; · 4.02 Impact Factor

A R Mundy